9 unknown. 9 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Unknown 9 |
| Phase 1 | 1 | Unknown 1 |
Follow Cryoablation: new trials by email Literature Review of Cryoablation trials Research Report on Cryoablation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma Cryoablation, PD-1 antibody and bevacizumab - Carcinoma, Hepatocellular | Phase 2 | Unknown | Shanghai Zhongshan Hospital | 36 | 2024-07-31 | 2024-07-31 |
| Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10) Cryoablation, Tislelizumab, Lenvatinib - Hepatocellular Carcinoma | Phase 2 | Unknown | Fudan University | 25 | 2023-06-20 | 2023-06-27 |
| Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09) Cryoablation, Tislelizumab, Lenvatinib - Gastric Cancer Metastatic to Liver | Phase 2 | Unknown | Fudan University | 25 | 2023-06-16 | 2023-06-27 |
| Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free) Cryoablation, Sintilimab, Lenvatinib - Advanced Intrahepatic Cholangiocarcinoma | Phase 2 | Unknown | Fudan University | 30 | 2023-04-28 | 2023-05-31 |
| Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08） Sintilimab, Lenvatinib, Cryoablation - Advanced Biliary Tract Cancer | Phase 2 | Unknown | Fudan University | 25 | 2023-03-23 | 2023-03-24 |
| Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis Tislelizumab, Lenvatinib, Cryoablation - Melanoma | Phase 2 | Unknown | Fudan University | 25 | 2022-07-15 | 2022-11-10 |
| Cryoablation Combined With Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma Camrelizumab; Apatinib - Hepatocellular Carcinoma | Phase 2 | Unknown | Sun Yat-sen University | 34 | 2021-09-01 | 2021-09-05 |
| A Phase 2 Trial for Patients With Metastatic Solid Cancer Keytruda Injectable Product, Yervoy Injectable Product, Cytoxan - Metastatic Cancer | Phase 2 | Unknown | Rampart Health, L.L.C. | 32 | 2021-05-19 | 2024-05-09 |
| Cryoablation Combined With Camrelizumab and Apatinib for Multiprimary Lung Cancer Camrelizumab and Apatinib - Lung Cancer | Phase 1 / Phase 2 | Unknown | ShiYue Li | 20 | 2019-12-01 | 2019-12-17 |
Carcinoma, Hepatocellular (3) · Lung Neoplasms (1) · Melanoma (1) · Neoplasm Metastasis (1)
Fudan University (5) · Rampart Health, L.L.C. (1) · Shanghai Zhongshan Hospital (1) · ShiYue Li (1) · Sun Yat-sen University (1)
China (7) · United States (1)
Peng Wang, MD (3) · David G Bostwick, M.D., M.B.A. (1) · Jian Zhou (1)